Examining EGFR-mediated PI3K/Akt pathway in combination therapy of cetuximab and dynamin inhibition

被引：0
|
作者：
Chew, Hui Yi [1 ]
Panizza, Benedict [2 ]
Cooper, Caroline [3 ]
Dolcetti, Riccardo [1 ]
Coward, Jim [4 ]
McCluskey, Adam [5 ]
Robinson, Phillip J. [6 ]
Wells, James W. [1 ]
Simpson, Fiona [1 ]
机构：
[1] Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia
[2] Univ Queensland, Princess Alexandra Hosp, Otolaryngol Head & Neck Surg Dept, Brisbane, Qld, Australia
[3] Princess Alexandra Hosp, Pathol Queensland, Brisbane, Qld, Australia
[4] Icon Canc Ctr, Brisbane, Qld, Australia
[5] Univ Newcastle, Ctr Chem Biol & Clin Pharmacol, Callaghan, NSW, Australia
[6] Univ Sydney, Childrens Med Res Inst, Cell Signalling Unit, Sydney, NSW, Australia
来源：
MOLECULAR CANCER RESEARCH | 2020年 / 18卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B12
引用
收藏
页码：47 / 47
页数：1
相关论文
共 50 条
  • [31] The PI3K/AKT/mTOR interactive pathway
    Ersahin, Tulin
    Tuncbag, Nurcan
    Cetin-Atalay, Rengul
    [J]. MOLECULAR BIOSYSTEMS, 2015, 11 (07) : 1946 - 1954
  • [32] PI3K/Akt signalling pathway and cancer
    Vara, JAF
    Casado, E
    de Castro, J
    Cejas, P
    Belda-Iniesta, C
    González-Barón, M
    [J]. CANCER TREATMENT REVIEWS, 2004, 30 (02) : 193 - 204
  • [33] Clonorchis sinensis Granulin Promotes Malignant Transformation of Hepatocyte Through EGFR-Mediated RAS/MAPK/ERK and PI3K/Akt Signaling Pathways
    Wang, Caiqin
    He, Qing
    Yin, Yingxuan
    Wu, Yinjuan
    Li, Xuerong
    [J]. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2021, 11
  • [34] Vertical inhibition of the PI3K/Akt/mTOR pathway is synergistic in breast cancer
    Woo, S-U
    Sangai, T.
    Akcakanat, A.
    Chen, H.
    Wei, C.
    Meric-Bernstam, F.
    [J]. ONCOGENESIS, 2017, 6 : e385 - e385
  • [35] Targeting cancer stem cells via inhibition of PI3K/AKT pathway alone and in combination with autophagy blockade
    Graham, Regina M.
    Middleton, Andrew
    Benito, Daniel A.
    Uddin, Raisa
    Zhang, Baoyu
    Walters, Winston
    Bregy, Amade
    Vanni, Steven
    Komotar, Ricardo J.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2015, 14 (07)
  • [36] Vertical inhibition of the PI3K/Akt/mTOR pathway is synergistic in breast cancer
    S-U Woo
    T Sangai
    A Akcakanat
    H Chen
    C Wei
    F Meric-Bernstam
    [J]. Oncogenesis, 2017, 6 : e385 - e385
  • [37] Geldanamycin Induces Motor Neuron Apoptosis by Inhibition of the PI3K/AKT Pathway
    Dennys, C. N.
    Gitto, S.
    Franco, M.
    Estevez, A.
    Strayer, A.
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2013, 24
  • [38] Inhibition of PI3K/Akt pathway increases chemosensitivity of gastric cancer to vincristine
    Xie Xia
    Zhang Peng-Bing
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 870 - 871
  • [39] Inhibition of the PI3K/Akt pathway increases the chemosensitivity of gastric cancer to vincristine
    Xie, Xia
    Tang, Bo
    Zhou, Jianyun
    Gao, Qing
    Zhang, Pengbing
    [J]. ONCOLOGY REPORTS, 2013, 30 (02) : 773 - 782
  • [40] MOLECULAR DETERMINANTS OF SENSITIVITY TO PI3K/AKT/mTOR PATHWAY INHIBITION IN GLIOBLASTOMA
    von Achenbach, Caroline
    Weller, Michael
    Kaulich, Kerstin
    Gramatzki, Dorothee
    Zacher, Angela
    Fabbro, Doriano
    Reifenberger, Guido
    Szabo, Emese
    [J]. NEURO-ONCOLOGY, 2018, 20 : 48 - 48
12345